INTERNATIONAL
CRIMINAL COURT
The
Hague
The
Netherlands
29
JULY 2006
REPLY REGARDING THE UNITED STATES CENTERS FOR DISEASE CONTROL, et al, AND THEIR SCIENTIFIC FRAUD AS CONCERNS “LYME DISEASE”
The
University of State of Connecticut (UCONN) experimented on Czech children with
a vaccine (LYMErix) that they knew would do them no good, and was this only
meant to be an experiment to determine how serious would be the vaccine
injuries to these children.
In
the United States we refer to this as being “human guinea pigs,” and why animal
rights campaigners waste everyone’s time and cause all the ruckus that they do,
availing the stupid FBI to be distracted with nonsense (which happens to be
their preference, because 9/11 was a false flag operation and the favorite
topic of the New Haven FBI is pornography, while they have this huge
international scientific fraud crime being conducted from Yale, right across
the street) while all this other deliberate harm to children occurs unchecked
is beyond reasoning to someone like myself who has always worked in the medical
field.
There
is none of that kind (B31) of LYMErix OspA in Europe, and SmithKline and Yale
and UCONN knew it at least 5 years pervious to this injury-experiment on Czech
children. In the United States, this
could be considered “assault,” since Yale had already proven that LYMErix did
not prevent Lyme disease. Yale only
proved that LYMErix made the spirochetes not only expand in ticks, but not express
OspA- which is the very nature of a relapsing fever borreliosis.
There’s
the proof. I gave this data to the local FBI and USDOJ but they all happen to
be idiots, which was why I had to contact the ICC.
All
Yale did was report the following report was Lyme was a relapsing fever
borreliosis and that no vaccine would ever work, since that is the nature of
the relapse.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=7729870%5BUID%5D
Infect Immun.
1995 May;63(5):1658-62.
Selection of variant Borrelia burgdorferi isolates from mice immunized with outer surface protein A or B.
Department of Internal Medicine, Yale University
School of Medicine, New Haven, Connecticut 06520-8031, USA.
A nonclonal population of Borrelia burgdorferi N40
(passage 3) that survived protective immunity following challenge inoculation
of outer surface protein (Osp) A- or B-hyperimmunized mice were characterized
for the molecular basis of evasion of immunity. Two of six B. burgdorferi
isolates, cultured from OspA-immunized mice, had antigenic diversity in the
carboxyl terminus of OspA and did not bind to the protective OspA monoclonal
antibody designated IXDII. However, OspA-immunized mice challenged with these
variants were fully protected. Moreover, B. burgdorferi isolates with a point
mutation in ospB, which results in a truncated OspB that does not bind to
protective OspB monoclonal antibody 7E6C, were frequently enriched after
infection of OspB-immunized mice. These studies suggest that the incomplete
efficacy of an OspA- or OspB-based vaccine may be partly due to immunomediated
in vivo selective pressure, resulting in the persistence of some spirochetes
that do not bind to protective antibodies.
These
organisms change their outer surface proteins constantly and people can be
infected with multiple “strains” rendering the immune system “completely
overwhelmed” (CDC’s Alan Barbour, now at the new CDC Level IV Bioweapons lab at
UCAL Irvine) for two reasons:
1)
too many new antigens
2)
immune suppression and resultant seronegativity
The
United States Centers for Disease Control knew in 1992 that OspA or any of
these lipoproteins would not work as a vaccine, because they themselves
conducted the experiment where they created a strain of borrelia spirochete
that did not have the OspA-B plasmid in it, simply by “selecting” “variants”
that don’t produce these OspA-B antibodies, by using OspA-B antibodies to
“select” them, because that is what is meant by RELAPSING FEVER BORRELIOSIS.
Here
is that report:
http://www.jem.org/cgi/reprint/176/3/799
This
is what happens in a mammal (human), too.
Not
only did the CDC report that there can never be a vaccine for Lyme in 1992,
they simultaneously reported that the current CDC testing for Lyme is bogus,
because just as there are varying strains and the “overwhelming of the immune
system,” the CDC is aware that not everyone presents with Lyme arthritis due to
their genetic background and this is what they mean by “MHC-restricted and
MHC-non-restricted antibodies” in their patents with SmithKline in Europe.
http://v3.espacenet.com/textdes?DB=EPODOC&IDX=AU4392093&F=8&QPN=AU4392093
“Summary of the Invention [from the CDC staff’s patents]:
”In one aspect, the invention provides isolated B. burgdorferi antigens which
are regulated and differentiated by growth of the B. burgdorferi in a tick
vector. Novel antigens of the invention are listed below in Table I.
”Certain of these antigens are characterized as being B. burgdorferi B31 strain
specific and major histocompatibility complex(MHC) nonrestricted. Certain other
of these antigens are characterized as being MHCrestricted. Sera generated to
these antigens (B31 MHC nonrestricted and B31 MHC restricted) are further
characterized by the ability or lack of ability to react with B. burgdorferi
JD-1 strain; the antigens themselves (B31 MHC nonrestricted and B31 MHC
restricted) are further characterized by being homologous or heterologous with
B. burgdorferi JD-1 strain antigens. The most preferred antigens of this
invention, because of their ability to induce cross-strain immunity to B.
burgdorferi in different animal haplotypes, are characterized by being B31 MHC nonrestricted,
JD-1 crossreactive, and JD-1 nonrestricted.Other antigens are also useful in
vaccine compositions and as diagnostics.”
In
addition to this clear patent claim, CDC explained even more clearly why there
can never be a vaccine for Lyme, and that their current testing for Lyme is
bogus for the very same reason, Alan Barbour (CDC Epidemiological Intelligence
Officer) published the explicit reason, in this report about ANTIGENIC
VARIATION IN VECTOR-BORNE PATHOGENS:
Antigenic variation in vector-borne pathogens.
University of California Irvine, Irvine, California
92697-4025, USA. abarbour@uci.edu
Several pathogens of humans and domestic animals
depend on hematophagous arthropods to transmit them from one vertebrate
reservoir host to another and maintain them in an environment. These pathogens
use antigenic variation to prolong their circulation in the blood and thus
increase the likelihood of transmission. By convergent evolution, bacterial and
protozoal vector-borne pathogens have acquired similar genetic mechanisms for
successful antigenic variation. Borrelia spp. and Anaplasma marginale (among
bacteria) and African trypanosomes, Plasmodium falciparum, and Babesia bovis
(among parasites) are examples of pathogens using these mechanisms.
Antigenic variation poses a challenge in the development of vaccines against
vector-borne pathogens.
It
clearly also poses a challenge for diagnosis. This means the CDC’s current bogus schema for the testing for
Lyme or any other borreliosis is bogus, and the same is true for the EUCALB and
the ALDF, the Department of Health and Human Services, and everyone else who is
well-paid to be a USA-dot-gov-idiot.
The
only valid testing for Lyme is in Borrelia specific flagellin antibody, in
antibody testing, since there is so much flagellin, and in Yale’s own patent
words, “THE VAST MAJORITY” of Lyme-infected people have band 41 or
antiflagellin antibody. Do look that
up. Yale does indeed make that claim in
US patent 5,618,533. Here’s the link to
the journal report that preceded the patent.
You will find that this research was funded by:
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=1894359
the
National Institutes of Health. So, we clearly
both have to A) pay for- and B) suffer- this FRAUD and abuse.
Why
it is okay for CDC to spin Lyme and also stand to profit personally from patent
licensure while simultaneously being in receipt of a paycheck that says DOT GOV
on it, denying people early and adequate care, guaranteeing permanent
disability not only for Americans but for the entire planet, rendering us
(again) at your doorstep?
We
think this is criminal, and an international crime of medical negligence and
FRAUD, far bigger than the stem cells fraud.
That Korean researcher never actually hurt a living soul. Lyme causes Lou Gehrigs’ Disease or
Amyotropic Lateral Sclerosis, which is not only deadly but a horrible illness
and death.
The
Connecticut Department of Mental Health and Addiction Services and Yale
University staff committed perjury under oath in America and said Lyme
borreliosis is not a brain disease, when Department of Energy and Department of
Defense staff at Brookhaven National Labs (Ray Dattwyler and Ben Luft at State
University of New York, Stony Brook) stated in a 1994 US Food and Drug
Administration meeting that Lyme spirochetes have invaded the brain in 2/3 of
the cases of a Lyme rash (and scanned in below):
http://www.actionlyme.org/Dattwyler_Luft_Bb_DNA_in_CSF.htm
Borrelioses
have always been known to be permanent brain infections, at least since World
War II, and this fact was reported in the literature here in the USA by the US
Uniformed Services Hospital staff in Bethesda, Maryland, and in Europe (Lancet,
by WWII British Army physicians and Wellcome Labs).
The
EUCALB is a false or “front” non-profit which is identical to the ALDF.com
bogus non-profit and they have identical disclaimers for “medical negligence”
for any physicians who follow their recommendations, yet the physician
organizations in the USA and the CDC state that they follow the ALDF/EUCALB
recommendations for diagnosis and treatment of Lyme disease.
We really and truly do not
have any intelligent life here in the UnItEd StAtEs of AmeЯIcA.
OspA
was the (LYMErix) vaccine, but if a person has that antibody, they don’t have
Lyme disease, according to Yale, the CDC, and UCONN, which is clearly
FRAUD. If this vaccine was specific
enough to prevent Lyme disease (100% specificity), then it is
certainly specific enough to detect Lyme disease.
Not
detecting Lyme disease early is the certain way to chronic disability because
of the tissue damage from chronic illness and the immune dysregulation caused
by these sticky triacyl lipopeptide fungal antigens which are the Outer Surface
Proteins or Osps. These types of fungal
antigens are also found in mycoplasmal (fungal infections). There has been no successful vaccine for
tuberculosis, because when tried, these recombinant lipoprotein vaccines
suppressed the immune system and resulted in an exacerbation of the infection.
Just
like LYMErix did.
Also:
Eur J
Immunol. 2003 Sep;33(9):2539-50.
Pathogenesis of Lyme neuroborreliosis: Borrelia
burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus
monkey astrocytes.
Division of Bacteriology and Parasitology, Tulane National
Primate Research Center, Tulane University Health Sciences Center, Covington,
LA 70433, USA.
Brain invasion by Borrelia burgdorferi, the agent of
Lyme disease, results in an inflammatory and neurodegenerative disorder called
neuroborreliosis. In humans, neuroborreliosis has been correlated with enhanced
concentration of glial fibrillary acidic protein in the cerebrospinal fluid, a
sign of astrogliosis. Rhesus monkeys infected by us with B. burgdorferi showed
evidence of astrogliosis, namely astrocyte proliferation and apoptosis. We
formulated the hypothesis that astrogliosis could be caused by spirochetal
lipoproteins. We established primary cultures of rhesus monkey astrocytes and
stimulated the cells with recombinant lipidated outer surface protein A
(L-OspA), a model B. burgdorferi lipoprotein, and
tripalmitoyl-S-glyceryl-Cys-Ser-Lys(4)-OH (Pam(3)Cys), a synthetic lipopeptide
that mimics the structure of the lipoprotein lipid moiety. L-OspA elicited not
only astrocyte proliferation but also apoptosis, two features observed during
astrogliosis. Astrocytes produced both IL-6 and TNF-alpha in response to L-OspA
and Pam(3)Cys. Proliferation induced by L-OspA was diminished in the presence
of an excess of anti-IL-6 antibody, and apoptosis induced by this lipoprotein
was completely suppressed with anti-TNF-alpha antibody. Hence, IL-6 contributes
to, and TNF-alpha determines, astrocyte proliferation and apoptosis,
respectively, as elicited by lipoproteins. Our results provide proof of the
principle that spirochetal lipoproteins could be key virulence factors in Lyme
neuroborreliosis, and that astrogliosis might contribute to neuroborreliosis
pathogenesis.
PMID: 12938230 [PubMed - indexed for MEDLINE]
Don’t
we think it is the slightest bit interesting that OspA (LYMErix) caused a loss
of brain-associated cells (apoptosis means auto-kill; the cells died)? This is the “vaccine,” after all.
These
Pam3Cys triacyl lipopeptides have the effect of turning off the immune system,
adhering to erythrocytes and producing irregularly formed lymphocytes, or
result in immune incompetence, exacerbation of latent infections, Borreliosis
infection results in the production of lymphocytes that are reminiscent of
Epstein-Barr transformed cells, and they cause general weakness (Paul Duray’s
chapter in “Lyme Disease, Molecular and Immunologic Approaches, Cold Spring
Harbor 1992 conference, by Steve Schutzer)

All
of these facts are known by the members of the ALDF.com and EUCALB, because I
am reciting their own research results.
Considering
the numbers of people here and in Eurasia who are disabled from borrelioses,
and who will in the future become disabled from borrelioses- and in particular
due to the fact of the fraud in testing perpetrated by Yale, UCONN, the CDC,
the EUCALB and the ALDF.com, this is certainly a crime against humanity,
because as previously reported to the UN, in April 2003, citing the Declaration
of Human Rights
http://www.actionlyme.org/UN_PETITION.htm
Article
2
What
we now know is that in any of these crazy reports by Yale wherein they now say
Lyme is a nothing-disease with no consequences, we know that is because they
are not using their validated and accurate Lyme borreliosis flagellin antibody
test, which is about 95% accurate according to Yale’s own validation, and the
criteria for the validation of a bioanalytical method per the US FDA rules.
- -
-
In
it fact may be true that SmithKline is more of your (ICC-Europe) problem than
the American’s FDA, since SmithKline is a British company, although Yale owns
the patent for LYMErix. SmithKline
manufactured it.
Imagine
what it is like living here in NUTCASE-ville, Corrupticut, with all these Yalie
psychopathic idiots running around, like “president” George W. Bush, Prescott
Bush, and Jonathan Bush - who is infamous for The Riggs Bank scandal, since
that happened while Uncle Jonathan Bush Warbucks was running that CIA Spook
Bank, and who laundered money for the dictator Pinochet, as well as holding
money for about 50 Saudi families, allegedly including funding the 9/11
hijackers, lending credibility to the argument that 9/11 was a controlled
demolition. Simultaneously, George W.
Bush’s brother Marvin Bush’s company was in charge of “security” for the World
Trade Center- the
very-heavily-insured-against-terrorists-attacks-World-Trade-Center, one
building of which collapsed due to sheer fright (WTC building 7). I guess the construction engineers who
designed the WTC hadn’t planned on these poor WTC buildings being “Shocked and
Awed” to death.
Do
help us out and take it upon yourselves to work up the specific violation, since
you know the situation is hopeless here in BULLSHIT-DEMOCRACY-LAND. Look how many people we killed in Iraq and
then the Neocons suddenly realized Chalabi was an Iranian spy, and we DIDN’T
get to steal their oil to pay ourselves for blasting the shit out their people
and their country.
Do you really
think America is a place from which we DON’T need to seek asylum or other
assistance? A Connecticut asylum-seeker
named Ritt Goldstein is quite famous for being harassed by the psycho NAZI
jack-booted psychopathic cops here in Corrupticut.. Google him. He’s hiding
in Europe somewhere, still. And it was
from CONNECTICUT that he escaped with his life. We suck.
Thank
you.
Kathleen
M. Dickson
23
Garden Street
Pawcatuck,
CT 06379
ActionLyme.org


